Nardine S. Abadeer

TL;DR: This work focuses on the developments and progress in nanoparticle design for photothermal cancer therapy since 2010, which includes in vitro and in vivo studies and the recent progression of gold nanoparticle photothermal therapy toward clinical cancer treatment.

TL;DR: The distance and plasmon wavelength dependent fluorescence of an infrared dye ("IRDye") bound to silica-coated gold nanorods and IRDye loading is limited to maintain a distance between dye molecules on the surface to more than 9 nm, well above the Förster radius, which assures minimal dye-dye interactions on thesurface of the nanoparticles.

TL;DR: Sub-50 nm pegylated mesoporous silica nanoparticles prepared with hydrothermal treatment show significantly improved biocompatibility and decreased macrophage uptake, making these nanoparticles viable for in vivo stealth drug delivery applications.

TL;DR: This Perspective highlights the synthetic achievements that have galvanized the field, presenting a comprehensive discussion of the mechanisms and products of both seed-mediated and alternative growth methods, and addresses recent breakthroughs and challenges in regiospecific functionalization, which is the next frontier in exploiting nanoparticle anisotropy.

TL;DR: The challenges of determining how thick the ligand shell is, how many ligands per nanorod are present on the surface, and where the ligands are located in regiospecific and mixed-ligand systems are addressed.